Mechanisms of resistance to chemotherapy in breast cancer and possible targets in drug delivery systems
Carregando...
Fontes externas
Fontes externas
Data
Orientador
Coorientador
Pós-graduação
Curso de graduação
Título da Revista
ISSN da Revista
Título de Volume
Editor
MDPI
Tipo
Resenha
Direito de acesso
Acesso aberto
Fontes externas
Fontes externas
Resumo
Breast cancer (BC) is one of the most important cancers worldwide, and usually, chemotherapy can be used in an integrative approach. Usually, chemotherapy treatment is performed in association with surgery, radiation or hormone therapy, providing an increased outcome to patients. However, tumors can develop resistance to different drugs, progressing for a more aggressive phenotype. In this scenario, the use of nanocarriers could help to defeat tumor cell resistance, providing a new therapeutic perspective for patients. Thus, this systematic review aims to bring the molecular mechanisms involved in BC chemoresistance and extract from the previous literature information regarding the use of nanoparticles as potential treatment for chemoresistant breast cancer.
Descrição
Palavras-chave
Idioma
Inglês
Citação
Pharmaceutics, v. 12, n. 12, p. 1-20, 2020.
